Spyre Therapeutics Inc (NAS:SYRE)
$ 30.39 1.44 (4.97%) Market Cap: 1.55 Bil Enterprise Value: 1.32 Bil PE Ratio: 0 PB Ratio: 7.07 GF Score: 51/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1